A box of the diabetes drug Ozempic rests on a pharmacy counter in Los Angeles, April 17, 2023.
Mario Tama | Getty Images
Blockbuster weight-loss drugs are priced significantly higher in the U.S. than in other large, high-income countries, according to a new analysis released Thursday.
The report from KFF, a health policy organization, comes as many U.S. health insurers balk at the extreme cost of weight-loss drugs and drop the medications from their plans.
At roughly $1,000 per month on average for medications that are typically taken over a long period of time, the drugs are straining insurers’ budgets. But many of the 100 million American adults who are obese can’t afford to pay out of pocket for the treatments, called GLP-1 agonists.
KFF compared list prices — the price a drugmaker sets before insurance or any discounts — available through website searches.
Some countries negotiate directly with drugmakers such as Novo Nordisk to set lower list prices for medications,…
2023-08-17 15:58:00
Post from www.cnbc.com